visiting relatives
Release time:
2020-08-14
Visiting Family
■ Employee's Children Xu Han
The last few days of last summer vacation coincided with the G20 Summit. My mother and I went to Simao, Yunnan, to visit my father working in Yunnan Jianfeng Cement Company.
Dad has been working in Yunnan for several years. Every time he goes home for vacation, he will tell me how beautiful Yunnan is and bring back many delicious snacks. It makes me yearn for Yunnan, which has the reputation of "the south of colorful clouds". He always looks forward to the blue sky and white clouds, clear water and green mountains, beautiful tropical rain forests and delicious tropical fruits there. This time I finally had the opportunity to experience my father's life, and I couldn't help jumping for joy when I set off.
After a bumpy ride, it was almost ten o'clock in the evening to Simao, so I stayed in a hotel in the city that night. The next morning, the sun just appeared, sleepy-eyed I was called up by my father and went to the factory with him in a daze.
just got off the bus, and the dust brought up by the wheel came oncoming, which completely "shot" me awake. I didn't feel refreshed until I left the road. I opened my eyes wide and looked at the place curiously: it was surrounded by mountains and full of lush woods, which made people feel very comfortable. All of a sudden, my eyes were attracted by a row of low houses not far away. I wanted to walk over and see, but my father told me that this was their dormitory building! Walking into his dormitory, I saw a small space with only one bed, which made people feel very crowded. Has Dad always lived here? I can't help but have a sore nose.
When I settled down and wanted to talk to my dad later, he was gone from the dormitory. Looking out of the window, he was walking towards the back of the factory in the distance.
Time went by one by one, and finally when Dad returned to "home" from work, his clean work clothes were covered with sweat and dust, and his face was full of fatigue, which was different from when he went out. Seeing this scene, I imagined that my father was busy in the factory. It must be very hard!
The leaders and colleagues of Dad's unit were very enthusiastic. Because of our arrival, everyone went to the nearby town for dinner after work. After the meal, the scene was dark. We walked back along the road. The lights in the factory looked like a long dragon or a silver snake from a distance. I can't express the details in words, but in this dark night, these lights were extremely gorgeous, just like the source of life, bringing hope to people...
In those days in Yunnan, the time spent with my father was always so short. He was busy at work every day, and after work, he accompanied us to the nearby town. Along the way, although my father accompanied me talking and laughing, I also felt his exhaustion. At that moment, I suddenly understood that every time I went back to Jinhua for vacation, my father never mentioned the hardships of his work. He always "reported the good news but not the bad news". It turned out that it was just to make us feel at home.
I want to say to dad: dad, you are working hard! (The author is the son of Song Xiaofei, a Yunnan peak employee)
Editor's Note: With the development of peak business, many peak people have walked out of the narrow Jinqu Basin, out of Zhejiang, away from their families, and in other places to explore and struggle. Their efforts and efforts have brought a broader space for development; the understanding and support of their families have also brought them the most powerful motivation. Here, we would like to "praise" all overseas employees and their families ".
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31